The results indicate increased neutrophil activation and free radical production after myocardial infarction; they also suggest that thrombolysis does not amplify the inflammatory response and may indeed suppress it.
Abstract Activated neutrophils releasing proteolytic enzymes and oxygen free radicals have been implicated in extending myocardial injury after myocardial infarction. Neutrophil elastase was used as a marker of neutrophil activation and the non-peroxide diene conjugate of linoleic acid was used as an indicator of free radical activity in 32 patients dfter acute myocardial infarction; 17 were treated by intravenous thrombolysis. Patients with acute myocardial infarction had higher plasma concentrations of neutrophil elastase and the non-peroxide diene conjugated isomer of linoleic acid than normal volunteers or patients with stable ischaemic heart disease. Patients treated by thrombolysis had an early peak of neutrophil elastase at eight hours while those who had not been treated by thrombolysis showed a later peak 40 hours after infarction. The plasma concentration of non-peroxide conjugated diene of linoleic acid was highest 16 hours after the infarction irrespective of treatment by thrombolysis. Quantitative imaging with single photon emission tomography showed decreased uptake of indium-111 labelled neutrophils in the infarcted myocardium (as judged from technetium-99m pyrophosphate) in those who had received thrombolysis, suggesting a decreased inflammatory response.
The results indicate increased neutrophil activation and free radical production after myocardial infarction; they also suggest that thrombolysis does not amplify the inflammatory response and may indeed suppress it.
Activation of neutrophils with release of lysosomal enzymes and production of oxygen free radicals is an important part of the host defence mechanism against microbial infection. Activated neutrophils, however, have been implicated in the pathogenesis of several disease processes including emphysema, adult respiratory distress syndrome, and myocardial infarction.' It has been suggested that the neutrophil may cause secondary heterolytic damage of myocytes, because neutrophil depletion limited infarct size in animal models of infarction2'; the damage was attributed to the release oflysosomal enzymes4 or free radical production. 5 Degranulation of neutrophils releases neutrophil elastase, a lysosomal enzyme; this has been used as a specific marker of neutrophil activation. " Activated neutrophils are one potential source of oxygen free radical production."' It is difficult to measure these unstable oxygen species but once they are generated they will react and oxidise adjacent molecules, particularly polyunsaturated fatty acids.'5 The diene conjugated non-peroxide isomer of linoleic acid (phospholipid 9, 11 -linoleic acid; PL-9, 11-LA') has been used as a marker of human free radical activity.'6 To determine if and when neutrophil activation takes place after myocardial infarction, we measured serial changes in plasma neutrophil elastase and PL-9, 1 1-LA'. We also investigated how these indices were influenced by reperfusion by studying patients treated with and without thrombolytic agents..Finally, because the acute inflammatory infiltrate within myocardium after myocardial infarction can be imaged, '7 we examined the effect of treatment with and without thrombolysis on the myocardial uptake of indium-1 1 1 labelled neutrophils.
Patients and methods

VALUES IN HEALTHY VOLUNTEERS AND PATIENTS WITH CHRONIC ISCHAEMIC HEART DISEASE
To establish a normal range for plasma concentrations of neutrophil elastase and the conjugated diene of linoleic acid, blood samples were taken from 35 healthy volunteers from laboratory and hospital staff. As a further control group we also studied 30 patients with a documented history of ischaemic heart disease based on coronary angiography (n = 12) or distant myocardial infarction (n = 18) (table 1). ) . There was no correlation between the white blood cell count and plasma concentration of neutrophil elastase in any of the groups. There was a weak correlation between white cell count and PL-9, 11-LA' in the non-thrombolytic group (r = 063, p < 0 02), and in patients with ischaemic heart disease (r = 0 45, p < 002), but this did not hold for the corrected molar ratio and no correlations were found in the normal volunteers and patients treated with thrombolysis.
IMAGING (TABLE 2)
In general, in the patients who were imaged there was a significantly greater number of voxels showing an uptake of 99mTc pyrophosphate than of "'In labelled neutrophils (p < 00006). Uptake of 9'9Tc pyrophosphate was very similar in patients who were treated by thrombolysis and those who were not, suggesting little difference in infarct size in these patients. This is supported by similar values of residual left ventricular ejection fraction and peak creatinine kinase in both groups (table 2) . In contrast, the uptake of "'In labelled neutrophils was less in the patients who were treated by thrombolysis. Thus the ratio of "'In/9Tc, which serves as an estimate of the inflammatory response for a given infarct size, was significantly less in patients treated by thrombolysis (041, range 00-96) than in those treated without (079, range 006-2-14, p < 0-05). In fig 2 an example of the greater uptake of "'In labelled neutrophils in a patient treated without thrombolysis is contrasted with that seen in a patient who had received streptokinase.
Discussion
We found both an increased neutrophil elastase release and an increase in the plasma concentrations of the diene conjugated non-peroxide isomer of linoleic acid (PL-9, 11-LA') after myocardial infarction. The association of leucocytosis and the severity of myocardial infarction was first described by White in 1926.1' We noted increased neutrophil leucocytosis after myocardial infarction but there was no correlation between the peripheral neutrophil count and the raised plasma concentrations of neutrophil elastase. A distinction must be made between whole blood elastase and plasma elastase. Whole blood elastase correlates with the total neutrophil count but is not a marker of neutrophil activation and reflects the much greater intracellular stores of the enzyme. Increased plasma neutrophil elastase relates to neutrophil degranulation and presumably reflects release within the area of myocardial injury. The peripheral leucocytosis is part of the more general response to stress.20 Like others we also noted an increased leucocyte count in patients with stable ischaemic heart disease and this has been shown to be a predictor of future myocardial events.2' The neutrophil has been recognised as an early part of the inflammatory response to myocardial infarction,2223 but it is only more recently that experimental evidence has been put forward to suggest that it may be involved in secondary heterolytic myocyte damage after myocardial infarction45 and that suppression of the neutrophil infiltrate can reduce infarct size.23 One mechanism by which activated neutrophils can induce cell damage is through the release of potent proteolytic enzymes.
Neutrophil elastase is a serine protease released from the primary granules after major cell stimulation such as phagocytosis or cell death.24 It has a wide range of substances including elastin, collagen, fibrinogen, and other matrix-macromolecules and is implicated in the pathogenesis of several human diseases.'
Our study showed that plasma concentrations of human neutrophil elastase were significantly higher in patients after myocardial infarction than in healthy volunteers and patients with stable ischaemic heart disease. Further, the pattern of elastase release was different in patients treated conventionally and in those treated with thrombolysis. In patients treated with streptokinase or anistreplase there was a significant early increase in plasma neutrophil elastase within the first few hours of treatment. This confirms previous observations25 and it seems likely that this represents clot lysis or intracoronary activation of neutrophils because few inflammatory cells will have migrated into myocardial tissue by this stage.2223
In contrast, in patients treated conventionally concentrations of neutrophil elastase reach a peak later, between 32 and 40 hours after the onset of symptoms, when the inflammatory infiltrate is present histologically and can be imaged.'7 Drug treatment, particularly hydrocortisone or lignocaine, might be expected to influence neutrophil behaviour. But a similar number of patients in both groups received lignocaine, which is known to depress neutrophil function in vitro.26 Also patients given hydrocortisone before streptokinase did not have lower "'In uptake by neutrophils or lower concentrations of elastase than patients treated with anistreplase, who did not receive hydrocortisone. This suggests that the results in the thrombolytic group are not influenced by the potential suppressive effect of hydrocortisone on the inflammatory response and neutrophil function. 27 Although the neutrophil is a source of cytotoxic oxygen species, there are other potential sources of oxygen free radical production after myocardial infarction, including the conversion of xanthine dehydrogenase to xanthine oxidase, mitochondrial production, the auto-oxidation of catecholamines, and the arachidonic acid cascade. 8 '3 It is unlikely that changes in dietary intake or bacterial flora would alter significantly in the 48 hours after myocardial infarction to account for the changes seen in plasma PL-9, 11-LA'. Also the concentrations were not increased in the patients with stable, but documented ischaemic heart disease and there was no change in linoleic acid, which is also affected by dietary intake.
Heparin was shown to increase 9,1 1-LA"'4-the assay method, which is designed to measure the molar concentration of 9,1 1-LA'and 9,12-LA esterified as phospholipids, also measures 9,11-LA' and 9,12-LA present as free fatty acids. Free fatty acids are increased by the lipolytic action of heparin though the magnitude of the response is often overestimated because the method does not take account of the extensive ex-vivo lipolysis. 35 In our study heparin is unlikely to have had any significant effect because the thrombolytic group received only intravenous heparin as an adjuvant to thrombolysis a mean of 18 hours 36 minutes after the onset of symptoms. The patients treated conventionally also received heparin but as a low dose subcutaneously. We noted no difference in the values of PL-9, 11-LA' between the two groups despite the widely different heparin regimens. The similarity of responses of the two groups also argues for a lack of effect of the thrombolytic drugs in themselves on PL-9, 11-LA'.
The concentration of PL-9, 11-LA' or the molar ratio did not correlate with creatine kinase measured on the same sample and it therefore seems unlikely that the raised concentrations are merely a marker of cell damage'5 and the evidence is consistent with the diene being a free radical marker in human beings. In general, in patients with myocardial infarction the values of PL-9, 11-LA' and the molar ratio were high initially and then fell; this suggests that maximum free radical generation occurs early. We were unable to detect any difference in the concentrations of PL-9, 11-LA' or the molar ratio of PL-9, 11 -LA'/PL-9, 12-LA between patients treated conventionally and those who received thrombolysis. This lack of difference in'the molar ratio (indeed it was somewhat lower in the group treated by thrombolysis) suggests that reperfusion was not associated with a delayed or secondary increase in free radical production with the potential for further myocardial damage. Even when samples were taken earlier (less than 6 houts after the onset of symptoms) we did not detect any difference in those treated by thrombolysis. We cannot exclude the immediate increase in free radical production after reperfusion shown in some animal studies. ' 
